Literature DB >> 14601025

Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3.

Fredrik Wiklund1, Elizabeth M Gillanders, Julie A Albertus, Anders Bergh, Jan-Erik Damber, Monica Emanuelsson, Diana L Freas-Lutz, Derek E Gildea, Ingela Göransson, MaryPat S Jones, Björn-Anders Jonsson, Fredrik Lindmark, Carol J Markey, Erica L Riedesel, Elisabeth Stenman, Jeffry M Trent, Henrik Grönberg.   

Abstract

BACKGROUND: Prostate cancer (CaP) is a common disorder with multiple genetic and environmental factors contributing to the disease. CaP susceptibility loci can be identified through genome-wide scans of high-risk families.
METHODS: Allele sharing at 405 markers, distributed across the genome, among 50 families with hereditary prostate cancer, ascertained throughout Sweden, was evaluated through linkage analyses. Genotype data were analyzed utilizing multipoint parametric and non-parametric methods.
RESULTS: Two regions provided suggestive evidence for linkage: 19p13.3 (marker D19S209, LOD = 2.91, P = 0.0001) and 5q11.2 (marker D5S407, LOD = 2.24, P = 0.0007). Additional regions with moderate evidence for linkage in the complete set of families, or stratified subsets, were observed on chromosome 1, 4, 6, 7, 8, and X.
CONCLUSIONS: Our results provide strong confirmatory evidence of linkage at 19q13.3 and 5q11.2. The lack of confirmation of linkage at several loci identified in other genome-wide scans emphasizes the need to combine linkage data between research groups. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601025     DOI: 10.1002/pros.10303

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect.

Authors:  Bao-Li Chang; Ethan M Lange; Latchezar Dimitrov; Christopher J Valis; Elizabeth M Gillanders; Leslie A Lange; Kathleen E Wiley; Sarah D Isaacs; Fredrik Wiklund; Agnes Baffoe-Bonnie; Carl D Langefeld; S Lilly Zheng; Mika P Matikainen; Tarja Ikonen; Henna Fredriksson; Teuvo Tammela; Patrick C Walsh; Joan E Bailey-Wilson; Johanna Schleutker; Henrik Gronberg; Kathleen A Cooney; William B Isaacs; Edward Suh; Jeffrey M Trent; Jianfeng Xu
Journal:  Hum Genet       Date:  2005-11-23       Impact factor: 4.132

Review 2.  A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.

Authors:  Chunming Gong; Xueying Hu; Yong Gao; Yunfei Cao; Feng Gao; Zengnan Mo
Journal:  Med Oncol       Date:  2010-01-23       Impact factor: 3.064

3.  Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.

Authors:  Joan P Breyer; Kate M McReynolds; Brian L Yaspan; Kevin M Bradley; William D Dupont; Jeffrey R Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

4.  Assessment of possible association between rs3787016 and prostate cancer risk in Serbian population.

Authors:  Zorana Z Nikolić; Goran N Brajušković; Dušanka Lj Savić Pavićević; Aleksandar S Kojić; Vinka D Vukotić; Saša M Tomović; Snežana J Cerović; Vladimir Filipović; Duro Mišljenović; Stanka P Romac
Journal:  Int J Clin Exp Med       Date:  2012-11-18

5.  Expression of Alpha Methylacyl CoA Racemase (AMACR) in Gastric Adenocarcinoma and Its Correlation with Helicobacter pylori Infection.

Authors:  Yamini Jindal; Anshul Singh; Ravikant Kumar; Kachnar Varma; Vatsala Misra; Sri Prakash Misra; Manisha Dwivedi
Journal:  J Clin Diagn Res       Date:  2016-10-01

6.  Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.

Authors:  Guangfu Jin; Jielin Sun; Sarah D Isaacs; Kathleen E Wiley; Seong-Tae Kim; Lisa W Chu; Zheng Zhang; Hui Zhao; Siqun Lilly Zheng; William B Isaacs; Jianfeng Xu
Journal:  Carcinogenesis       Date:  2011-08-19       Impact factor: 4.944

Review 7.  From steroid receptors to cytokines: the thermodynamics of self-associating systems.

Authors:  Keith D Connaghan; Amie D Moody; James P Robblee; James R Lambert; David L Bain
Journal:  Biophys Chem       Date:  2011-04-27       Impact factor: 2.352

8.  Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.

Authors:  N K Mukhopadhyay; J Kim; S You; M Morello; M H Hager; W-C Huang; A Ramachandran; J Yang; B Cinar; M A Rubin; R M Adam; S Oesterreich; D Di Vizio; M R Freeman
Journal:  Oncogene       Date:  2013-07-29       Impact factor: 9.867

9.  Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease.

Authors:  Liesel M FitzGerald; Briony Patterson; Russell Thomson; Andrea Polanowski; Stephen Quinn; Jesper Brohede; Timothy Thornton; David Challis; David A Mackey; Terence Dwyer; Simon Foote; Garry N Hannan; James Stankovich; James D McKay; Joanne L Dickinson
Journal:  Eur J Hum Genet       Date:  2008-10-01       Impact factor: 4.246

10.  Prostate cancer risk-associated genetic markers and their potential clinical utility.

Authors:  Jianfeng Xu; Jielin Sun; S Lilly Zheng
Journal:  Asian J Androl       Date:  2013-04-08       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.